XML 45 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Information - Summary of Segment Activity (Details) - USD ($)
$ in Thousands
3 Months Ended
Jul. 31, 2016
Jul. 31, 2015
Segment Reporting Information [Line Items]    
Net revenue $ 3,670 $ 2,822
Sales and marketing costs (925) (1,029)
Stock- based compensation expense (1,129) (775)
Consolidated [Member]    
Segment Reporting Information [Line Items]    
Net revenue 3,670 2,822
Direct cost of services (2,477) (2,222)
Sales and marketing costs (757) (909)
Other operating expenses (1,830) (1,813)
Stock- based compensation expense (1,129) (775)
Segment profit (loss) (2,523) (2,897)
Operating Segments [Member] | Personalized Oncology Solutions [Member]    
Segment Reporting Information [Line Items]    
Net revenue 511 485
Direct cost of services (472) (634)
Sales and marketing costs (141) (332)
Other operating expenses 0 0
Stock- based compensation expense 0 0
Segment profit (loss) (102) (481)
Operating Segments [Member] | Translational Oncology Solutions [Member]    
Segment Reporting Information [Line Items]    
Net revenue 3,159 2,337
Direct cost of services (2,005) (1,588)
Sales and marketing costs (616) (577)
Other operating expenses (1,126) (933)
Stock- based compensation expense 0 0
Segment profit (loss) (588) (761)
Corporate, Non-Segment [Member]    
Segment Reporting Information [Line Items]    
Net revenue 0 0
Direct cost of services 0 0
Sales and marketing costs 0 0
Other operating expenses (704) (880)
Stock- based compensation expense (1,129) (775)
Segment profit (loss) $ (1,833) $ (1,655)